Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure

@inproceedings{Luo2019RelationshipBH,
  title={Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure},
  author={Nancy Luo and Steven J Lippmann and Robert J. Mentz and Melissa A. Greiner and Bradley G. Hammill and Natalie Chantelle Hardy and Warren K. Laskey and Paul A. Heidenreich and Chun‐Lan Chang and Adrian F. Hernandez and Lesley H. Curtis and Pamela N. Peterson and Gregg C Fonarow and Emily C O'Brien},
  booktitle={Journal of the American Heart Association},
  year={2019}
}
Background The angiotensin-receptor/neprilysin inhibitor ( ARNI ) sacubitril/valsartan reduces hospitalization and mortality for patients with heart failure with reduced ejection fraction. However, adoption of ARNI into clinical practice has been slow. Factors influencing use of ARNI have not been fully elucidated. Using data from the Get With The Guidelines-Heart Failure registry, Hospital Compare, Dartmouth Atlas, and the American Hospital Association Survey, we sought to identify hospital… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Similar Papers

Loading similar papers…